Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will present ...

NASHVILLE, Tenn., July 30, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics, or iMDx, (Nasdaq: IMDX), today announced two favorable oral abstracts, including one late-breaking, that will be ...

Tumors of the central nervous system (CNS) are the most common pediatric tumor type and the leading cause of cancer-related ...

Liquid biopsies have transformed cancer testing. These tests detect signs of cancer using a simple blood draw instead of ...

Prima Mente launches Pleiades, a human epigenome foundation model with applications for Alzheimer’s disease: London Saturday, July 19, 2025, 18:00 Hrs [IST] San Francisco and Lo ...

Prima Mente today announced the launch of Pleiades, a family of large-scale foundation models created to understand the epigenomic and molecular landscape of human disease. Pleiades represents ...

Therefore, we investigated whether HPV-human DNA junctions could be detected circulating in serum cell-free DNA (cfDNA), and whether they could be used to assess residual disease following initial ...

PURPOSEBlood-based liquid biopsy has enabled minimally invasive molecular profiling in patients with solid tumors. For cancers of the CNS, however, the use of peripheral blood for cell-free DNA (cfDNA ...

Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR 2025 Congress ...